Kymera Therapeutics, Inc. (NASDAQ:KYMR) is set to unveil results from its Phase 1 clinical trial of KT-621, a first-in-class ...

In the control arm, 43% of patients crossed over to receive Trodelvy monotherapy after disease progression, representing 81% of those who received any subsequent treatment following chemo-Keytruda, ...

What is Loud? A Web3 experiment on Solana that turns social attention into tradable value through the $LOUD token and ...

Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the ...

An international clinical trial shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.

There have been important recent advances in the management of Crohn's disease, including new classes of biological or small molecule therapies, an appreciation that endoscopic mucosal healing results ...

One of the toughest challenges in the base campaign of Xenoblade Chronicles X might just be the intimidating boss of Chapter ...

Fort Cavazos leaders are moving forward with the implementation of the Army’s Deferred Resignation Programs while remaining ...

Austin Energy is in phase two of restoration, which are areas that affect most people. Phase one was public safety infrastructure. Poles are being brought in, crew members are on poles, in bucket ...

A SpaceX launch of a GPS satellite Friday marked the latest national security mission taken away from United Launch Alliance ...

Regeneron and Sanofi face setbacks as itepekimab stumbles in phase 3. Click here to read why I believe SNY and REGN stocks ...